Back to home
VTRS logo

Is VTRS (Viatris Inc.) Halal or Haram?

NASDAQ Global SelectHealthcareDrug Manufacturers - Specialty & Generic$17.27B2026-04-29
VTRS is Doubtful3/4 screens passed

While Viatris operates in a completely permissible healthcare sector with zero interest income, its massive debt burden makes it doubtful for Muslim investors. The company's debt-to-market capitalization ratio sits at an alarming 85.1%, far exceeding the AAOIFI threshold of 33%. Consequently, despite passing the cash and interest income screens, the stock fails the overall shariah compliance test due to excessive leverage.

Price Chart (5D)

$16.19+0.55 (+3.52%)
2026-06-092026-06-02

VTRS — Last 7 Days

DateOpenHighLowCloseVolumeChange
2026-06-0916.1316.4115.9316.207.8M+0.43%
2026-06-0816.0516.1815.7915.939.3M-0.75%
2026-06-0515.8716.1915.8615.889.0M+0.06%
2026-06-0415.7015.9915.6415.907.5M+1.27%
2026-06-0315.6815.7215.5015.567.0M-0.77%
2026-06-0215.8715.9315.6015.699.0M-1.13%
2026-06-0116.1716.1715.7315.8112.5M-2.23%

Discussion

Sign in to join the discussion

Loading comments...

Shariah Screening Details for VTRS

Business Activity

Permissible

Viatris passes the business activity screen as its core operations in producing prescription brands, complex generics, and active pharmaceutical ingredients are entirely permissible under Islamic finance principles.

Debt / Market Cap

85.11%

Debt: $14.70BThreshold: ≤33%

Interest Income

0.00%

Interest: $0Threshold: ≤5%

Cash & Securities

8.42%

Cash: $1.45BThreshold: ≤33%

About Viatris Inc. (VTRS)

Viatris Inc. is a global healthcare giant specializing in prescription brand drugs, complex generics, and biosimilars. The company supplies critical medications across various therapeutic areas, including oncology, immunology, and cardiovascular health, as well as active pharmaceutical ingredients (APIs) to markets worldwide.

For Muslim investors using HalalStocks.co.uk, Viatris is currently classified as Doubtful under AAOIFI standards. Although its core pharmaceutical business is entirely halal and it comfortably passes the interest income and cash screens, it critically fails the leverage test, meaning investors should avoid the stock for now.

The primary concern from an Islamic finance perspective is Viatris's excessive debt load, with a debt-to-market cap ratio of 85.1%, severely breaching the 33% limit. Fortunately, the company relies purely on its operational revenue rather than interest-bearing investments, boasting a perfect 0.00% interest income to revenue ratio.

Since the non-compliance stems entirely from its capital structure rather than its life-saving business activities, Muslim investors should closely monitor Viatris's balance sheet. If the company successfully pays down its debt or its market capitalization increases significantly, it could potentially cross back into shariah-compliant territory in the future.

CEO

Scott Andrew Smith

Employees

32,000

IPO Date

1980-03-17

Headquarters

Canonsburg, PA, US

VTRS Key Financial Statistics

Revenue

$14.30B

Net Income

$-3.51B

EPS (Diluted)

$-3.00

Stock Price

14.84

Beta

0.82

52-Week Range

8.19-16.47

Total Debt

$14.70B

Total Equity

$14.71B

Current Ratio

1.30

VTRS Financial Health & Profitability

Profit Margins

Gross Margin35.1%
Operating Margin-18.6%
Net Margin-24.6%

Revenue Growth (YoY)

-3.0%

Prior year: $14.74B

Net Debt

$13.35B

Cash: $1.35B — Debt: $14.70B

R&D Spending

$965.9M

% of Revenue

6.8%

Frequently Asked Questions About VTRS

Is VTRS (Viatris Inc.) stock halal to invest in?
Based on our AAOIFI-standard shariah screening, VTRS is classified as Doubtful. It passed 3 of 4 compliance screens. Some scholars may permit investing with income purification, while others advise avoiding it. We recommend consulting a qualified Islamic scholar before investing in VTRS.
What does Viatris Inc. do?
Viatris Inc. is a global healthcare giant specializing in prescription brand drugs, complex generics, and biosimilars. The company supplies critical medications across various therapeutic areas, including oncology, immunology, and cardiovascular health, as well as active pharmaceutical ingredients (APIs) to markets worldwide. For Muslim investors using HalalStocks.co.uk, Viatris is currently classified as Doubtful under AAOIFI standards. Although its core pharmaceutical business is entirely halal and it comfortably passes the interest income and cash screens, it critically fails the leverage test, meaning investors should avoid the stock for now. The primary concern from an Islamic finance perspective is Viatris's excessive debt load, with a debt-to-market cap ratio of 85.1%, severely breaching the 33% limit. Fortunately, the company relies purely on its operational revenue rather than interest-bearing investments, boasting a perfect 0.00% interest income to revenue ratio. Since the non-compliance stems entirely from its capital structure rather than its life-saving business activities, Muslim investors should closely monitor Viatris's balance sheet. If the company successfully pays down its debt or its market capitalization increases significantly, it could potentially cross back into shariah-compliant territory in the future. Viatris Inc. operates in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry and is headquartered in Canonsburg, PA, US. The company is led by CEO Scott Andrew Smith and employs approximately 32,000 people.
What screening criteria were used for VTRS?
VTRS was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. VTRS passed 3 of these 4 screens.
When was VTRS last screened?
VTRS was last screened on 2026-04-29. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.

Disclaimer

This shariah compliance assessment for VTRS (Viatris Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.

Other Screened Stocks in Healthcare